hypogonadism; oral t; jatenzo; adrenal function

https://clinicaltrials.gov/study/NCT06385509 Study Overview Brief Summary TOL-CLAR-20024 is a Phase 4, multi-center, open-label safety study evaluating the potential effect of JATENZO on adrenal function in hypogonadal men treated with JATENZO for 12 months. Detailed Description Following...